ATE125698T1 - Erosionsgesteuertes freisetzungssystem für wirkstoffe sowie verfahren zu dessen herstellung. - Google Patents

Erosionsgesteuertes freisetzungssystem für wirkstoffe sowie verfahren zu dessen herstellung.

Info

Publication number
ATE125698T1
ATE125698T1 AT90101889T AT90101889T ATE125698T1 AT E125698 T1 ATE125698 T1 AT E125698T1 AT 90101889 T AT90101889 T AT 90101889T AT 90101889 T AT90101889 T AT 90101889T AT E125698 T1 ATE125698 T1 AT E125698T1
Authority
AT
Austria
Prior art keywords
active agent
adjuvants
erosion
active agents
swelling
Prior art date
Application number
AT90101889T
Other languages
English (en)
Inventor
Udo Prof Dr Wenzel
Juergen Dr Metzner
Horst Dr Nindel
Halvor Dr Jaeger
Zoser B Dr Salama
Original Assignee
Int Pharma Agentur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DD32535389A external-priority patent/DD295759A5/de
Priority claimed from DE19893933000 external-priority patent/DE3933000A1/de
Application filed by Int Pharma Agentur filed Critical Int Pharma Agentur
Application granted granted Critical
Publication of ATE125698T1 publication Critical patent/ATE125698T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
  • Sorption Type Refrigeration Machines (AREA)
AT90101889T 1989-01-31 1990-01-31 Erosionsgesteuertes freisetzungssystem für wirkstoffe sowie verfahren zu dessen herstellung. ATE125698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DD32535389A DD295759A5 (de) 1989-01-31 1989-01-31 Erosionsgesteuertes arzneistofffreigabesystem und verfahren zu seiner herstellung
DE19893933000 DE3933000A1 (de) 1989-10-03 1989-10-03 Erosionsgesteuertes wirkstoff-freigabesystem und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
ATE125698T1 true ATE125698T1 (de) 1995-08-15

Family

ID=25748260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90101889T ATE125698T1 (de) 1989-01-31 1990-01-31 Erosionsgesteuertes freisetzungssystem für wirkstoffe sowie verfahren zu dessen herstellung.

Country Status (15)

Country Link
EP (1) EP0381182B1 (de)
JP (1) JPH02282322A (de)
KR (2) KR900011455A (de)
AT (1) ATE125698T1 (de)
AU (1) AU637782B2 (de)
CA (1) CA2009044A1 (de)
DE (1) DE69021224T2 (de)
DK (1) DK0381182T3 (de)
ES (1) ES2078252T3 (de)
FI (1) FI900469A7 (de)
GR (1) GR3017785T3 (de)
HU (1) HU205850B (de)
IE (1) IE69555B1 (de)
NO (1) NO900427L (de)
RU (1) RU2079301C1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
SK281042B6 (sk) 1992-09-18 2000-11-07 Yamanouchi Pharmaceutical Co., Ltd Prípravok hydrogélového typu s ustáleným uvoľňovaním
CN1143680C (zh) * 1997-08-14 2004-03-31 阿旺蒂斯制药公司 增强非索非那定及其衍生物之生物利用度的方法
ES2226886T3 (es) * 1999-08-31 2005-04-01 Grunenthal Gmbh Forma de administracion de accion retardada que contiene sacarinato de tramadol.
RU2203062C2 (ru) * 2000-10-13 2003-04-27 Закрытое акционерное общество "ФАРМАПЭК" Бронхолитическое средство и способ его получения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2055930A1 (de) * 1970-11-13 1972-05-18 Boehringer Mannheim Gmbh, 6800 Mannheim Verbesserte orale Applikationsform von Raubasin
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
GB8716975D0 (en) * 1987-07-17 1987-08-26 Boots Co Plc Therapeutic agents
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition

Also Published As

Publication number Publication date
DK0381182T3 (da) 1995-10-30
KR900011455A (ko) 1990-08-01
IE900335L (en) 1990-07-31
NO900427D0 (no) 1990-01-30
KR910007515A (ko) 1991-05-30
FI900469A0 (fi) 1990-01-30
DE69021224D1 (de) 1995-09-07
AU4898790A (en) 1990-08-09
ES2078252T3 (es) 1995-12-16
NO900427L (no) 1990-08-01
EP0381182B1 (de) 1995-08-02
CA2009044A1 (en) 1990-07-31
HU205850B (en) 1992-07-28
GR3017785T3 (en) 1996-01-31
RU2079301C1 (ru) 1997-05-20
AU637782B2 (en) 1993-06-10
EP0381182A2 (de) 1990-08-08
JPH02282322A (ja) 1990-11-19
EP0381182A3 (de) 1991-01-09
FI900469A7 (fi) 1990-08-01
DE69021224T2 (de) 1996-04-04
IE69555B1 (en) 1996-10-02

Similar Documents

Publication Publication Date Title
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
PL319373A1 (en) Method of producing single doses by wet granulation
AU8052487A (en) Controlled release hydromorphone composition
GB2264640B (en) Microcrystalline cellulose spheroids comprising hydromorphone and a sugar
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
HUP9903308A2 (hu) Granulátum nagy mennyiségű hatóanyagot tartalmazó, gyorsan széteső és gyorsan oldódó készítmények előállítására
NO307594B1 (no) Fremgangsmåte for fremstilling av en tørr, hydratisert cefalosporinpulverformulering, og farmsøytisk preparat
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
NO982902D0 (no) FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen
IS3789A7 (is) Aðferð við framleiðslu lyfjaskammta í föstu formimeð tempraðri losun virks þáttar
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
ATE125698T1 (de) Erosionsgesteuertes freisetzungssystem für wirkstoffe sowie verfahren zu dessen herstellung.
KR100679872B1 (ko) 사이클로포스파미드 제피 정제 및 이의 제조방법
IE870577L (en) Topical amide preparation
ATE72118T1 (de) Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
CA1105835A (en) Pharmaceutical tablet comprising anti-allergic drug
AU621677B2 (en) Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
MY105595A (en) Stable aqueous solutions of primycin pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
YU20050413A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem
RU93049414A (ru) Производные бенз(е)индена
GB1570994A (en) Pharmaceutical formulation